多药与老年人认知障碍之间的关联:系统性审查和元分析
Xiaoyun Yu1, Ying Qian1, Yudie Zhang1
1School of Nursing, Hangzhou Normal University, Hangzhou, PR China.
概括
多药性,即使用多种药物,与老年人认知障碍的风险更高有关. 这一关联凸显了在这个人群中需要谨慎的药物管理的需要.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 多药在老年人中很常见.
- 认知障碍在老年人群中越来越令人担忧.
研究的目的:
- 调查60岁以上个体中多药与认知障碍之间的关联.
- 量化与老年人药物使用相关的认知衰退风险.
主要方法:
- 在主要数据库 (Cochrane,PubMed,Web of Science,Embase,CINAHL) 进行系统的文献搜索.
- 使用固定或随机效应模型进行观察性研究的元分析.
- 使用推分级,评估开发和评估 (GRADE) 系统对证据的质量评估.
主要成果:
- 分析了27项涉及超过1.24亿老年人的研究.
- 多种药物 (≥5种药物) 显著增加了认知障碍的风险 (OR = 1.39,95% CI: 1.23-1.58).
- 过度使用多种药物 (≥10种药物) 也与认知障碍有显著的关联 (OR = 1.51,95% CI: 1.01-2.25).
结论:
- 多药与老年人认知障碍之间存在潜在的关联.
- 需要进一步的研究才能确定确切的因果关系.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
112
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
112
Cognitive Development During Adulthood
72
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
72
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
108
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
108


